News from QUARTET



QUARTET members met on 3 November 2022 in Brussels to discuss ongoing or planned trials and research activities. Site approvals and plan evaluations are in progress for FaR-RMS (EpSSG), HRMB (SIOPE Brain Tumour Group), LINES (SIOPEN), HR-NBL2 (SIOPEN), and VERITAS (SIOPEN). Setup is in progress for QUARTET-affiliated trials investigating questions for Ewing sarcoma, non-rhabdomyosarcoma soft-tissue sarcomas, advanced-teratoid rhabdoid tumours, and Wilms tumours.

The QUARTET group is currently recruiting for a one-year research fellowship, as Andrada Turcas’ fellowship comes to an end. You can find out more about her experience as a QUARTET fellow here.

The full fellowship announcement is available here.  

To learn more about the project or get involved please refer to the QUARTET concept paper, published in the European Journal of Cancer, as well as the website.